Published in Obesity and Diabetes Week, June 6th, 2005
"Joe brings 25 years of successful commercial pharmaceutical management and product experience to Nektar's board. Krivulka's commercial acumen and broad experience will be particularly helpful as Nektar builds and advances our proprietary products program," said Robert Chess, executive chairman of Nektar.
Krivulka founded Triax Pharmaceuticals and has been president since November...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.